| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.07 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |